17449-96-6|Clofezone|2-(4-chlorophenoxy)-N-(2-(diethylamino)ethyl)acetamide compound with 4-butyl-1,2-diphenylpyrazolidine-3,5-dione (11)|-范德生物科技公司

Clofezone

NMR下载 COA and HPLC MSDS下载
names：
2-(4-chlorophenoxy)-N-(2-(diethylamino)ethyl)acetamide compound with 4-butyl-1,2-diphenylpyrazolidine-3,5-dione (11)
CAS号：
17449-96-6
MDL Number：
MF(分子式)： C33H41ClN4O4 MW(分子量)： 593.17
EINECS: Reaxys Number:
Pubchem ID: Brand:BIOFOUNT

货品编码	规格	纯度	价格 (¥)	现价(¥)	特价(¥)	库存描述	数量	总计 (¥)

大包装询价提供各种包装，敬请垂询
收藏商品商品点评加入购物车立即购买

快速询价

收起

你想询价的产品

*产品名称：

CAS号：

产品编号：

需求描述：

请准确填写您的联系方式，以便为您提供最好的服务。

*公司名称：

*电子邮箱：

联系人：

*电话：

*验证码：

询价

中文别名	Clofezone
英文别名	Clofezone; Perclusone; Clofezonum
CAS号	17449-96-6
SMILES	O=C(NCCN(CC)CC)COC1=CC=C(Cl)C=C1.O=C(C2CCCC)N(C3=CC=CC=C3)N(C4=CC=CC=C4)C2=O
Inchi	InChI=1S/C19H20N2O2.C14H21ClN2O2/c1-2-3-14-17-18(22)20(15-10-6-4-7-11-15)21(19(17)23)16-12-8-5-9-13-16;1-3-17(4-2)10-9-16-14(18)11-19-13-7-5-12(15)6-8-13/h4-13,17H,2-3,14H2,1H3;5-8H,3-4,9-11H2,1-2H3,(H,16,18)
InchiKey	ICBCZMIEENEERJ-UHFFFAOYSA-N
分子式 Formula	C33H41ClN4O4
分子量 Molecular Weight	593.17
闪点 FP
熔点 Melting point
沸点 Boiling point
Polarizability极化度
密度 Density
蒸汽压 Vapor Pressure
溶解度Solubility
性状	Solid powder
储藏条件 Storage conditions	Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).

产品说明	Clofezone(CAS:17449-96-6):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。
Introduction	Clofezone, also known as Perclusone, is an analgesic and antipyretic with anti-inflammatory properties used in treatment of rheumatism.
Application1
Application2
Application3

警示图
危险性	Warning
危险性警示
安全声明
安全防护
备注

[1]Brackertz D. Comparison of clofezone and diclofenac in the treatment of out-patients suffering from activated (painful) osteoarthrosis. Z Rheumatol. 1978 Sep-Oct;37(9-10):342-9. PubMed PMID: 153679.

[2]Reinicke C, Helbing M, Klingenfeld U, Lasaroff I, Wessel G. [Comparative studies on the bioavailability of various drug forms of phenylbutazone and clofezone (Perclusone)]. Pharmazie. 1984 Dec;39(12):824-7. German. PubMed PMID: 6241720.

[3] Celik CM. [Experiences in the management of rheumatoid diseases using different clofezone doses]. Z Rheumatol. 1976 May-Jun;35(5-6):240-7. German. PubMed PMID: 133565.

[4] Tamura T. [Clofezone and oxyphenbutazone excluded from dental use]. Nihon Shika Ishikai Zasshi. 1984;37(4):391-5. Japanese. PubMed PMID: 6241218.

[5] Keitel W, Weber G, Hoffmann H. [Results of comparative clinical examinations of antirheumatics: clofezone, indomethacin, phenylbutazone]. Schweiz Rundsch Med Prax. 1971 Jan 5;60(1):18-21. German. PubMed PMID: 5313620.

6: David-Chaussé J, David-Chaussé F, Lagoarde J, Picot C. [Therapeutic study of an anti-inflammatory agent, Clofezone]. J Med Bord. 1967 Oct;144(10):1529-35. French. PubMed PMID: 5304355.7: Stroescu I, Stoicescu M, Dragomir M, Burtea A, Pintea G, Stoia I. [Value of clofezone in the treatment of rheumatic diseases]. Schweiz Rundsch Med Prax. 1971 Feb 16;60(7):217-20. French. PubMed PMID: 5555631.8: Machtey I. [Short term clofezone therapy in rheumatic diseases]. Harefuah. 1971 Jun 5;80(12):654-6. Hebrew. PubMed PMID: 5156431.9: Kaiser H. [Clofezone, a new potent antirheumatic drug]. Munch Med Wochenschr. 1973 Dec 7;115(49):2247-8. German. PubMed PMID: 4205416.10: Ogawa K, Oguchi J, Okada S. [Use of clofezone (pans) in oral surgery]. Shikai Tenbo. 1978;51(2):385-9. Japanese. PubMed PMID: 161230.1

对不起，暂无产品评价！

MSDS

SDS 1.0 中文

展开

SDS 1.0 英文

展开